BSE filing, NSE: MONEYBOXX. Summary written from the filing by ALFA Finder's alert engine.
Moneyboxx Finance Ltd: key numbers
- Share price
- ₹47.00
- Market cap
- ₹328.1 Cr
- Revenue (annual)
- ₹231.8 Cr
- Net profit (annual)
- ₹1.34 Cr
- P/E (TTM)
- 251.5×Sector 19.7×
- Promoter holding
- 46.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Moneyboxx Finance Ltd
All →Moneyboxx Finance Debt & Borrowing: ₹0.21 Cr
Moneyboxx Finance paid Rs.0.21 Crore interest on its Rs.25 Crore secured NCDs on October 26, 2026. The payment was made before the October 28 due date.
- Value
- ₹0.21 Cr
Moneyboxx Finance Debt & Borrowing: ₹1.18 Cr
Moneyboxx Finance paid Rs. 1.18 Crore interest on three listed secured NCD series on 22 October 2026. Payments were made ahead of due dates.
- Value
- ₹1.18 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.44 Cr
Moneyboxx Finance Limited has successfully paid interest of Rs.0.44 Crore on its senior secured non-convertible debentures for the period ending October 2026.
- Value
- ₹0.44 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.34 Cr
Moneyboxx Finance paid ₹0.34 Crore in monthly interest on its senior secured NCDs. The payment was completed on October 14, 2026.
- Value
- ₹0.34 Cr
Moneyboxx Finance Debt & Borrowing: ₹0.07 Cr
Moneyboxx Finance Ltd successfully paid Rs.0.07 Crore interest on its non-convertible debentures for the period ending October 2026.
- Value
- ₹0.07 Cr
Moneyboxx Finance Other Announcement
Moneyboxx Finance Limited has submitted the updated contact details of its Compliance Officer and Registrar and Share Transfer Agent (RTA).
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date